| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.2 | 0.002 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.2 | 0.003 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.15 | 0.004 |